Treatment, survival, and costs of laryngeal cancer care in the elderly

Laryngoscope

Volumn 124, Issue 8, 2014, Pages 1827-1835

  Gourin, Christine G ^a   Dy, Sydney M ^b,c   Herbert, Robert J ^c,d   Blackford, Amanda L ^b   Quon, Harry ^b   Forastiere, Arlene A ^b,d   Eisele, David W ^a   Frick, Kevin D ^c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

chemotherapy; costs; elderly; Laryngeal neoplasms; radiation; squamous cell cancer; surgery; Surveillance, Epidemiology, and End Results Medicare; survival; treatment

Indexed keywords

CETUXIMAB; FLUOROURACIL; PLATINUM; TAXANE DERIVATIVE;

AGED; CANCER SURVIVAL; CHEMORADIOTHERAPY; CONSERVATIVE TREATMENT; CROSS-SECTIONAL STUDY; FEMALE; GERIATRIC DISORDER; HEALTH CARE COST; HEALTH CARE QUALITY; HIGH VOLUME HOSPITAL; HUMAN; LARYNX SQUAMOUS CELL CARCINOMA; LARYNX TUMOR; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SALVAGE THERAPY; VERY ELDERLY;

CHEMOTHERAPY; COSTS; ELDERLY; LARYNGEAL NEOPLASMS; RADIATION; SQUAMOUS CELL CANCER; SURGERY; SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS-MEDICARE; SURVIVAL; TREATMENT;

AGED; AGED, 80 AND OVER; COSTS AND COST ANALYSIS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LARYNGEAL NEOPLASMS; MALE; NEOPLASMS, SQUAMOUS CELL; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84904716904     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.24574     Document Type: Review

References (28)

1. The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Eng J Med 1991; 324: 1685-1690.
2. Forastiere A, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Eng J Med 2003; 349: 2091-2098.
3. Weber RS, Berkey BA, Forastiere A, et al. Outcome of salvage total laryngectomy following organ preservation therapy: the Radiation Therapy Oncology Group Trial 91-11. Arch Otolaryngol Head Neck Surg 2003; 129: 44-49.
4. Hoffman HT, Karnell LH, Funk GF, et al. The National Cancer Data Base report on cancer of the head and neck. Arch Otolaryngol Head Neck Surg 1998; 124: 951-962.
5. Hoffman HT, Porter K, Karnell LH, et al. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope 2006; 116 (suppl 111): 1-13.
6. Chen AY, Schrag N, Hao Y, et al. Changes in treatment of advanced laryngeal cancer 1985-2001. Otolaryngol Head Neck Surg 2006; 135: 831-837.
7. Chen AY, Fedewa S, Zhu J,. Temporal trends in the treatment of early- and advanced-stage laryngeal cancer in the United States, 1985-2007. Arch Otolaryngol Head Neck Surg 2011; 137: 1017-1024.
8. Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006; 354: 567-578.
9. Machtay M, Moughan J, Trotti A, et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 2008; 26: 3582-3589.
10. Ullman CD, Harlan LC, Shavers VL, Stevens JL,. A population-based study of therapy and survival for patients with head and neck cancer treated in the community. Cancer 2012; 118: 4452-4461.
11. Pignon JP, le Maitre A, Maillard E, et al. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomized trials and 17,346 patients. Radiother Oncol 2009; 92: 4-14.
12. Lin LL, Hahn SM,. Combined modality therapy in the elderly population. Curr Treat Options Oncol 2009; 10: 195-204.
13. Lefebvre JL, Ang KK,; Larynx Preservation Consensus Panel. Larynx preservation clinical trial design: key issues and recommendations-a consensus panel study. Head Neck 2009; 31: 429-441.
14. American Society of Clinical Oncology, Pfister DG, Laurie SA, Weinstein GS, et al. American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol 2006; 24: 3693-3704.
15. US Census Bureau. 2012 national population projections: summary tables. Available at: http://www.census.gov/population/projections/data/national/2012/ summarytables.html. Accessed June 9, 2013.
16. 2013 annual report of the boards of trustees of the Federal Hospital Insurance and Federal Supplementary Medical Insurance Trust Funds. Available at: http://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and- Reports/ReportsTrustFunds/Downloads/TR2013.pdf. Accessed June 9, 2013.
17. National Cancer Institute. Cancer prevalence and cost of care projections. Available at: http://costprojections.cancer.gov/graph.php. Accessed June 7, 2013.
18. Charlson ME, Pompei P, Ales KL, Mackenzie CR,. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383.
19. Deyo RA, Cherkin DC, Ciol MA,. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45: 613-619.
20. Klabunde CN, Potosky AL, Legler JM, et al. Development of a comorbidity index using physician claims data. J Clin Epidemiol 2000; 53: 1258-1267.
21. Snyder CF, Frick KD, Blackford AL, et al. How does initial treatment choice affect short and long-term costs for clinically localized prostate cancer? Cancer 2010; 116: 5391-5399.
22. National Comprehensive Cancer Network. NCCN guidelines for head and neck cancer care. Available at: http://www.nccn.org/professionals/physician-gls/PDF/ head-and-neck.pdf. Accessed June 9, 2013.
23. Wolf GT,. Routine computed tomography scanning for tumor staging in advanced laryngeal cancer: implications for treatment selection. J Clin Oncol 2010; 28: 2315-2317.
24. Chen AY, Pavluck A, Halpern M, Ward E,. Impact of treating facilities' volume on survival for early-stage laryngeal cancer. Head Neck 2009; 31: 1137-1143.
25. Chen AY, Fedewa S, Pavluck A, Ward EM,. Improved survival is associated with treatment at high-volume teaching facilities for patients with advanced stage laryngeal cancer. Cancer 2010; 116: 4744-4752.
26. Birkmeyer JD, Sun Y, Wong SL, Stukel TA,. Hospital volume and late survival after cancer surgery. Ann Surg 2007; 245: 777-783.
27. The Leapfrog Group. Evidence based hospital referral. Available at: http://www.leapfroggroup.org/for-hospitals/leapfrog-safety-practices/ evidence-based-hospital-referral. Accessed June 9, 2013.
28. Gourin CG, Frick KD,. National trends in laryngeal cancer surgery and the effect of surgeon and hospital volume on short-term outcomes and cost of care. Laryngoscope 2012; 122: 88-94.